OurCrowd Portfolio Company MigVax: Tests Show Promising Results as COVID Vaccine Booster

OurCrowd portfolio company MigVax Ltd., a startup developing an oral subunit vaccine against COVID-19, has announced promising results from preclinical tests that demonstrated the effectiveness of its MigVax-101 booster for previously vaccinated persons. According to a note distributed by the company, tests carried out on… Read More
Read more in: Offerings, Global | Tagged israel, migvax, ourcrowd